Related Experiment Video

Updated: Jun 2, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

Epidemiology of Transfusion Related Acute Lung Injury in France: Preliminary Results

Philippe Renaudier1, Syvie Schlanger, Mai-Phuong Vo Mai

  • 1Unité d'Hémovigilance, Hôpital de la Croix Rousse, Hospices Civils de Lyon, France.

Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|April 23, 2011
PubMed

Insights

Transfusion-related acute lung injury (TRALI) is a serious adverse event. In France, packed red cells and platelets cause most TRALI cases, not fresh frozen plasma.

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Patient Safety

Background:

  • The French Hemovigilance Network monitors adverse events from labile blood product (LBP) transfusions.
  • Established in 1994, it collects data on transfusion reactions and their severity.

Purpose of the Study:

  • To analyze the incidence and characteristics of transfusion-related acute lung injury (TRALI) in France.
  • To identify the labile blood products most frequently associated with TRALI.
  • To inform prevention strategies for TRALI.

Main Methods:

  • Analysis of data from the French Hemovigilance Network between 1994 and 2006.
  • Inclusion of all notified adverse transfusion reactions and specifically TRALI cases.
  • Categorization of TRALI cases by the type of labile blood product involved.

Main Results:

  • Over 35 million LBP were issued, with 85,812 adverse reactions and 139 TRALI cases reported.
  • Fresh frozen plasma (FFP), platelets concentrates (PC), and packed red cells (PRC) were implicated in TRALI.
  • PRC and PC accounted for the majority of TRALI cases, while FFP was associated with approximately 10%.
  • No cases of TRALI involved pooled FFP treated with solvent-detergent.
  • Patients experiencing TRALI often had a significant underlying disease burden.

Conclusions:

  • Targeting prevention solely on FFP would yield minimal reduction in TRALI incidence in France.
  • Packed red cells and platelets concentrates are the primary labile blood products associated with TRALI in the French context.
  • Understanding the specific blood products involved is crucial for effective TRALI prevention strategies.

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...